MEI Pharma (MEIP) Insider Trading & Ownership $6.20 +0.06 (+0.98%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$6.02▼$6.3450-Day Range$5.66▼$7.8452-Week Range$4.00▼$8.60Volume50,978 shsAverage Volume79,957 shsMarket Capitalization$41.31 millionP/E Ratio1.00Dividend YieldN/APrice Target$24.50 Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability MEI Pharma (NASDAQ:MEIP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.90%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$1.07 MNumber OfInsiders Selling(Last 12 Months)0 Get MEIP Insider Trade Alerts Want to know when executives and insiders are buying or selling MEI Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MEIP Insider Buying and Selling by Quarter MEI Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/22/2023Anson Funds Management LpMajor ShareholderBuy48,060$6.85$329,211.00 9/20/2023Anson Funds Management LpMajor ShareholderBuy120,000$6.01$721,200.00 2/28/2023Charles V Baltic IIIDirectorBuy4,075$4.60$18,745.00 (Data available from 1/1/2013 forward) MEIP Insider Trading Activity - Frequently Asked Questions Who is on MEI Pharma's Insider Roster? The list of insiders at MEI Pharma includes Anson Funds Management Lp, Charles V Baltic III, and Frederick W Driscoll. Learn more on insiders at MEIP. What percentage of MEI Pharma stock is owned by insiders? 3.90% of MEI Pharma stock is owned by insiders. Learn more on MEIP's insider holdings. Which MEI Pharma insiders have been buying company stock? The following insiders have purchased MEIP shares in the last 24 months: Anson Funds Management Lp ($1,050,411.00), and Charles V Baltic III ($18,745.00). How much insider buying is happening at MEI Pharma? Insiders have purchased a total of 172,135 MEIP shares in the last 24 months for a total of $1,069,156.00 bought. More Insider Trading Tools from MarketBeat Related Companies: HCW Biologics Insider Selling Celularity Insider Selling Rain Oncology Insider Selling Hookipa Pharma Insider Selling Societal CDMO Insider Selling Lantern Pharma Insider Selling Minerva Neurosciences Insider Selling Yumanity Therapeutics Insider Selling Bolt Biotherapeutics Insider Selling Rezolute Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The most active insider sales: Stocks to put on your radarChoose these agricultural stocks to finish the year strongFeel like buying the dip on Best Buy? Your gut may be rightThe top 3 stocks insiders are selling, but you shouldn’tSimon Property Group's 7.2% Dividend Has Insiders Buying In Bulk This page (NASDAQ:MEIP) was last updated on 12/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.